Nath Bio-Genes Q2 Results FY27: Revenue Down 7.09% YoY to Rs 40.74 Cr, PAT Rs 0.42 Cr
- November 14, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Nath Bio-Genes Q2 Results FY27 were declared on 14 November 2026, with consolidated revenue of Rs 40.74 Cr, down 7.09% YoY, and net profit of Rs 0.42 Cr, down 84.73% YoY. These quarterly results cover July to September 2026. The YoY growth figures sit beside Operating Profit of Rs 4.64 Cr against Rs 6.10 Cr a year earlier, a move of -23.93% YoY.
Nath Bio-Genes (India) Ltd (NATHBIOGEN) Q2 Results FY27 announced on 14 November 2026, covering the company’s financial performance for the July to September quarter. The results date brings consolidated results with revenue of Rs 40.74 Cr and PAT of Rs 0.42 Cr, against Rs 2.75 Cr a year earlier. This Nath Bio-Genes Q2 Results FY27 report sets out each figure in full.
This Nath Bio-Genes Q2 Results results analysis covers the financial highlights, the business drivers, the outlook and the risks that sit beside the numbers. Univest Screener users can follow the same disclosures, and the Financial Highlights below place the reported figures side by side.
Click Here – Get Free Investment Predictions
Nath Bio-Genes Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 40.74 Cr | Rs 43.85 Cr | -7.09% YoY |
| Operating Profit | Rs 4.64 Cr | Rs 6.1 Cr | -23.93% YoY |
| Net Profit (PAT) | Rs 0.42 Cr | Rs 2.75 Cr | -84.73% YoY |
Source: company filing for Nath Bio-Genes Q2 Results FY27, 14 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Nath Bio-Genes Q2 Results: What Stands Out
- Revenue: Rs 40.74 Cr in the quarter, down 7.09% from Rs 43.85 Cr in the same quarter last year, the YoY growth figure for the top line.
- Net profit: Rs 0.42 Cr against Rs 2.75 Cr a year earlier, a move of -84.73% that sets the quarter’s bottom line against the earlier level.
- Operating Profit: Rs 4.64 Cr compared with Rs 6.10 Cr, a change of -23.93% over the same period.
- Basis: In Nath Bio-Genes Q2 Results FY27, every figure is drawn from the consolidated results for July to September 2026.
- Next step: The performance analysis that follows places revenue, Operating Profit and net profit side by side for the quarter.
Nath Bio-Genes Q2 Results FY27: Performance Analysis
Revenue fell 7.09% YoY to Rs 40.74 Cr, net profit fell 84.73% YoY to Rs 0.42 Cr and Operating Profit fell 23.93% YoY to Rs 4.64 Cr. The numbers in Nath Bio-Genes Q2 Results FY27 therefore give a clear read of the three reported lines on a consolidated basis, which is the main pattern for investors to register.
On the results analysis, the Rs 0.42 Cr net profit compares with Rs 2.75 Cr recorded a year earlier, and revenue is set against a prior-year base of Rs 43.85 Cr. In Nath Bio-Genes Q2 Results FY27, the YoY growth in each line is read against the same July to September quarter of the previous year.
Investors will want to follow the next quarterly results for the same three lines, reported on the same consolidated basis, to see how the trajectory develops after the results date of 14 November 2026. The supplied figures confirm what changed but do not establish the specific cause, and in Nath Bio-Genes Q2 Results that is why the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Improved Return on Capital Employed – The results analysis points first to this factor: Return on capital employed improved to 7.88% in FY26 from 6.90% in FY25. This sits alongside the quarterly results and the reported Operating Profit of Rs 4.64 Cr. This fact sits alongside the quarter’s reported figures and leads to what the FY27 outlook may depend on.
FY27 Outlook After Nath Bio-Genes Q2 Results
The FY27 outlook depends on the quarters still to be reported, and the first half of the year is only one input. This results analysis covers July to September 2026 alone, so full-year FY27 figures will follow from the results date of 14 November 2026 only as later quarterly results are declared and disclosed sector conditions become clear to investors.
Nath Bio-Genes Q2 Results FY27 give a net profit base of Rs 0.42 Cr for the second quarter, and later disclosures will show how that figure compares in the coming quarters. Univest app users can follow each new filing as it is declared, which leads into the risks that sit beside these numbers.
Key Risks to Watch After Nath Bio-Genes Q2 Results FY27
Revenue Decline
Revenue declined 7.1% year on year to Rs 40.74 Cr in the latest quarter. This top line decline is read alongside the Operating Profit move of -23.93% YoY, since both lines were lower in July to September 2026.
Net Profit Fall
Net profit fell 84.7% year on year to Rs 0.42 Cr. This bottom line fall sits beside the revenue decline, and the quarter’s Rs 0.42 Cr is the latest reading in that series.
Narrower Net Profit Margin
Net profit margin narrowed to 1.0% from 6.3% in the comparison quarter. After Nath Bio-Genes Q2 Results FY27, this margin reading is a reference point for judging how the quarterly figures carry into later periods.
Low Return on Equity
Return on equity was low at 6.28% in FY26. This full-year ratio is a reference point for judging how the quarterly figures sit against the company’s wider record.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Nath Bio-Genes Q2 Results FY27 show consolidated revenue of Rs 40.74 Cr, Operating Profit of Rs 4.64 Cr and net profit of Rs 0.42 Cr for July to September 2026. Taken together, these quarterly results give investors a YoY picture, and Consolidated results are the basis for every figure above. Anyone reading Nath Bio-Genes Q2 Results should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Nath Bio-Genes Q2 Results FY27
What are Nath Bio-Genes Q2 Results FY27?
Ans. Nath Bio-Genes Q2 Results FY27 cover the July to September 2026 quarter, with consolidated revenue of Rs 40.74 Cr and net profit of Rs 0.42 Cr, while the Key Takeaways section lists each reported figure in turn.
What is the results date for Nath Bio-Genes Q2 Results FY27?
Ans. The results date is 14 November 2026, when the company declared its July to September 2026 quarter. Alongside this, the filing is on a consolidated basis, as the Quick Answer explains.
What revenue was reported in Nath Bio-Genes Q2 Results FY27?
Ans. Nath Bio-Genes Q2 Results FY27 report revenue of Rs 40.74 Cr for the quarter. This compares with Rs 43.85 Cr a year earlier, so the Performance Analysis section shows revenue down 7.09% YoY.
What net profit was reported in Nath Bio-Genes Q2 Results FY27?
Ans. Nath Bio-Genes Q2 Results FY27 show net profit of Rs 0.42 Cr for the quarter. This compares with Rs 2.75 Cr a year earlier, which means net profit fell 84.73%, as the Key Takeaways section notes.
How much YoY growth did revenue show in Nath Bio-Genes Q2 Results FY27?
Ans. Revenue moved -7.09% YoY, from Rs 43.85 Cr to Rs 40.74 Cr in the quarter. Alongside this YoY growth figure, net profit moved -84.73%, which the Performance Analysis section covers in detail.
Did net profit rise or fall in Nath Bio-Genes Q2 Results?
Ans. Net profit fell in Nath Bio-Genes Q2 Results, from Rs 2.75 Cr to Rs 0.42 Cr, a change of -84.73%. Alongside this, Operating Profit fell, so the Key Takeaways section lists both movements.
What was the Operating Profit in Nath Bio-Genes Q2 Results FY27?
Ans. Operating Profit was Rs 4.64 Cr, compared with Rs 6.10 Cr a year earlier. This is a change of -23.93%, which means the Key Takeaways section treats it alongside revenue and net profit.
Are Nath Bio-Genes Q2 Results consolidated results or standalone results?
Ans. The figures are consolidated results, as declared with the filing on 14 November 2026. So every revenue, Operating Profit and net profit figure above uses the consolidated basis, as the opening paragraphs state.
What business factors shaped Nath Bio-Genes Q2 Results FY27?
Ans. The disclosed factor is return on capital employed improving to 7.88% in FY26 from 6.90% in FY25. Alongside this, the Key Business Factors section places that ratio beside Operating Profit of Rs 4.64 Cr.
What are the key risks after Nath Bio-Genes Q2 Results FY27?
Ans. The risks are a 7.1% revenue decline, a net profit fall of 84.7%, a narrower net profit margin of 1.0% and return on equity of 6.28% in FY26, as the Key Risks to Watch section lists.
What is the outlook after Nath Bio-Genes Q2 Results?
Ans. Full-year FY27 results will depend on subsequent quarters and the disclosed conditions around them. So the FY27 Outlook section tracks net profit across later quarterly results, starting from Rs 0.42 Cr.
Where can I find the complete Nath Bio-Genes Q2 Results FY27 data?
Ans. The complete figures sit in the Financial Highlights table in this article, compared with the same quarter last year. Alongside it, Univest Screener lets readers follow later filings for the same company.
